Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT

NCT04168528 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumor
Breast Cancer
Melanoma (Skin)

Interventions

DRUG: 68GaNOTA-Anti-MMR-VHH2

Sponsor

Universitair Ziekenhuis Brussel

Collaborators

[object Object]